Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment.
Applications of optical coherence tomography in pediatric clinical neuroscience.
The HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical Practice.
Multiple Sclerosis treatment and infectious issues: Update 2013.
Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis.
Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range.
Implications of dietary salt intake for multiple sclerosis pathogenesis.
Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?
Exploration of Undertreatment and Patterns of Treatment of Depression in Multiple Sclerosis.
Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: Role in myelin repair.
Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST-T2) at 3T.
PSEUDOBULBAR AFFECT IN MULTIPLE SCLEROSIS PATIENTS.
Metaboreflex activity in multiple sclerosis patients.
[Anesthetic Management of Three Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Undiagnosed neurological disease as a potential cause of male lower urinary tract symptoms.
Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis.
Enzyme activity assays for protein kinases: Strategies to identify active substrates.
Obesity and brain inflammation: a focus on multiple sclerosis.
Midkine: an emerging target of drug development for treatment of multiple diseases.
Laquinimod, an upcoming oral immunomodulatory agent for treatment of multiple sclerosis.
Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks.
Cognitive and Affective Assessments of Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO) Patients Utilizing Computerized Touch Panel-type Screening Tests.
[Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica : Therapy option for acute relapses during pregnancy and breastfeeding.]
Microglia and neuroprotection.
Therapeutic management of severe relapses in multiple sclerosis.
Pages
« first
‹ previous
…
620
621
622
623
624
625
626
627
628
…
next ›
last »